Thomas Verjus

Through a low-carbon journey from Europe to Asia, I interviewed 15 impact leaders to tell and convey our new climate and societal imaginaries through the documentary series intothegood.com.

On key themes: eco-responsible fashion, sustainable food, agroecology, water, climate policy, low-carbon culture, media...

For each episode, I write a complete article in French and English and produce a video.

Its production allowed me to research our climate and societal challenges to better support my professional transition, from the health sector to the impact sector, with initial freelance missions starting in 2025.

As an international sales director, I developed a client portfolio generating $2 million in annual revenue from the sale of real-world patient studies and data science consulting services to key global pharmaceutical industry accounts: USA, EMEA, LatAm, and APAC.

I worked with VPs, Heads, and Directors from R&D, clinical trials, market access/HEOR, medical affairs, and sales teams across multiple therapeutic areas (oncology, immunology, neurology, endocrinology...) to help them generate patient outcomes and leverage them in their drug launch strategy with health authorities and KOLs.

I was responsible for all key stages of the sales cycle: prospecting, pitching and sales meetings, preparation of commercial proposals and pricing, client negotiation, and contracting.

I also coordinated marketing activities with the dedicated team: sales deck, new professional website, paid campaigns, LinkedIn posts, newsletters, webinars, and press releases.

I reported directly to our Head of BD RWE and worked closely with the Group CEO on key client and partnership matters, as well as with our Head of Data Science.

Responsible for a portfolio of key accounts in the pharmaceutical industry globally for the sale of real-world patient studies and RWE.

EvidentIQ was born from the merger of Carenity with two clinical software players: Marvin (DE) and Fortress Medical Systems (USA).